General MedicationsINJECTIONGeneric
FACTREL
GONADORELIN HYDROCHLORIDE
Standard Dose
EQ 0.1MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary
Approval overview FACTREL is listed in Drugs@FDA under application 018123 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient GONADORELIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 0.1MG BASE/VIAL Sponsor HIKMA Submission history Latest submission status date: 2002-07-19 00:00:00.
Structured Monograph
Clinical summary
Approval overview FACTREL is listed in Drugs@FDA under application 018123 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient GONADORELIN HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 0.1MG BASE/VIAL Sponsor HIKMA Submission history Latest submission status date: 2002-07-19 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.